ETON
Price
$55.38
Change
+$3.40 (+6.54%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.69B
34 days until earnings call
Intraday BUY SELL Signals
SIGA
Price
$3.40
Change
+$0.04 (+1.19%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
248.6M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ETON vs SIGA

ETON vs SIGA Comparison Chart in %
View a ticker or compare two or three
VS
ETON vs. SIGA commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETON is a Hold and SIGA is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ETON vs SIGA: Fundamental Ratings
ETON
SIGA
OUTLOOK RATING
1..100
7631
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
5100
SMR RATING
1..100
2991
PRICE GROWTH RATING
1..100
3562
P/E GROWTH RATING
1..100
369
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is significantly better than the same rating for ETON (80) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew significantly faster than ETON’s over the last 12 months.

ETON's Profit vs Risk Rating (5) in the Pharmaceuticals Major industry is significantly better than the same rating for SIGA (100) in the Pharmaceuticals Other industry. This means that ETON’s stock grew significantly faster than SIGA’s over the last 12 months.

ETON's SMR Rating (29) in the Pharmaceuticals Major industry is somewhat better than the same rating for SIGA (91) in the Pharmaceuticals Other industry. This means that ETON’s stock grew somewhat faster than SIGA’s over the last 12 months.

ETON's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as SIGA (62) in the Pharmaceuticals Other industry. This means that ETON’s stock grew similarly to SIGA’s over the last 12 months.

SIGA's P/E Growth Rating (9) in the Pharmaceuticals Other industry is in the same range as ETON (36) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew similarly to ETON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ETONSIGA
RSI
ODDS (%)
Bearish Trend 3 days ago
70%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (ETON: $51.98 vs. SIGA: $3.35)
Brand notoriety: ETON and SIGA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ETON: 207% vs. SIGA: 82%
Market capitalization -- ETON: $1.69B vs. SIGA: $248.6M
ETON [@Pharmaceuticals: Generic] is valued at $1.69B. SIGA’s [@Pharmaceuticals: Generic] market capitalization is $248.6M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETON’s FA Score shows that 2 FA rating(s) are green while SIGA’s FA Score has 2 green FA rating(s).

  • ETON’s FA Score: 2 green, 3 red.
  • SIGA’s FA Score: 2 green, 3 red.
According to our system of comparison, ETON is a better buy in the long-term than SIGA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETON’s TA Score shows that 2 TA indicator(s) are bullish while SIGA’s TA Score has 5 bullish TA indicator(s).

  • ETON’s TA Score: 2 bullish, 7 bearish.
  • SIGA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SIGA is a better buy in the short-term than ETON.

Price Growth

ETON (@Pharmaceuticals: Generic) experienced а -12.62% price change this week, while SIGA (@Pharmaceuticals: Generic) price change was +3.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.71%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +29.84%.

Reported Earning Dates

ETON is expected to report earnings on Nov 05, 2026.

SIGA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.71% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
ETON
Daily Signal:
Gain/Loss:
SIGA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HARD34.330.65
+1.93%
Simplify Commodities Strategy No K-1 ETF (HARD)
UGL46.150.42
+0.92%
ProShares Ultra Gold (UGL)
SNPG60.000.31
+0.52%
Xtrackers S&P 500 Growth Scored & Screened ETF (SNPG)
SCHV33.380.07
+0.21%
Schwab U.S. Large-Cap Value ETF (SCHV)
GPZ21.34-0.01
-0.05%
Vaneck Alternative Asset Manager ETF

SIGA and

Correlation & Price change

A.I.dvisor tells us that SIGA and EBS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGA and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
-1.47%
EBS - SIGA
33%
Poorly correlated
-3.48%
ETON - SIGA
28%
Poorly correlated
+0.95%
HROW - SIGA
26%
Poorly correlated
-0.62%
AMRX - SIGA
25%
Poorly correlated
-0.35%
SBFM - SIGA
25%
Poorly correlated
-11.07%
More